Company Filing History:
Years Active: 2010
Title: **Inventor Rolf Hoerlein: Pioneering Therapeutic Innovations**
Introduction
Rolf Hoerlein, an esteemed inventor based in Frankfurt-am-Main, Germany, has made significant contributions to the field of medicinal chemistry. With a focus on developing innovative processes, his work aims to enhance the treatment options available for various central nervous system disorders.
Latest Patents
Rolf Hoerlein holds one patent for a revolutionary method titled "Method for the production of diarylcycloalkyl derivatives." This invention pertains to a specific process for preparing diarylcycloalkyl derivatives that act as activators for peroxisome proliferator-activated receptors (PPARs). These compounds are particularly beneficial in the therapeutic treatment of diseases such as multiple sclerosis, Parkinson's disease, and various psychiatric disorders. Notably, Hoerlein's process allows for producing PPAR activators with high enantioselectivity, avoiding common disadvantages associated with previous methods.
Career Highlights
Currently, Rolf Hoerlein is affiliated with Sanofi-Aventis Deutschland GmbH, a prominent player in the global pharmaceuticals industry. His research and innovation in drug development reflect his commitment to improving therapeutic outcomes for patients with challenging medical conditions.
Collaborations
Throughout his career, Rolf Hoerlein has collaborated with notable colleagues, including Christophe Salagnad and Frank Zocher. These collaborations underscore the importance of teamwork in advancing scientific discovery and its practical applications in medicine.
Conclusion
Rolf Hoerlein's innovative approach to medical chemistry and his patent for the production of diarylcycloalkyl derivatives position him as a key figure in developing effective treatments for central nervous system disorders. His contributions, alongside collaborative efforts with esteemed colleagues, continue to inspire advancements in the pharmaceutical field, ultimately benefiting patient care and health outcomes.